Association between adjusted atherogenic index of plasma and major adverse cardiovascular events after percutaneous coronary intervention in patients with STEMI: a prospective observational study in China
Objectives The atherogenic index of plasma (AIP) has been reported as a biomarker for cardiovascular disease risks and clinical outcomes. However, few studies have investigated the relationship between the AIP and major adverse cardiovascular events (MACEs) after percutaneous coronary intervention (...
Saved in:
| Main Authors: | Dong Wu, Xiaoying Wang, Ya Li, Xiaojuan Wang, Xiaowu Wang, Zhenfeng Yang, Zhen M A, Yongkai Ma, Guangli Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-08-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/15/8/e096065.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association between the atherogenic index of plasma and major adverse cardiovascular events in patients with premature coronary artery disease
by: Xiangzhen Ran, et al.
Published: (2025-06-01) -
Prognostic significance of the Tpe/Qtc ratio in predicting major adverse cardiac events in acute STEMI patients
by: Evren Dal, et al.
Published: (2025-07-01) -
Predictors of the Development of Major Adverse Cardiac Events following Percutaneous Coronary Intervention
by: Nouha Azaza, et al.
Published: (2022-03-01) -
The predictive value of atherogenic index of plasma and clonal hematopoiesis of indeterminate potential among patients with STEMI—from a prospective cohort study
by: Xiaoxiao Zhao, et al.
Published: (2025-08-01) -
Atherogenic index of plasma as an additional marker of adverse cardiovascular outcomes
by: Yu. I. Grinshtein, et al.
Published: (2022-06-01)